No description available.

Endocannabinoid signaling is well studied in mammals and known to be involved in numerous pathological and physiological processes. Fatty acid amide hydrolase (FAAH) terminates endocannabinoid signaling in mammals. In Physcomitrella patens, we identified nine orthologs of FAAH (PpFAAH1 to PpFAAH9) with the characteristic catalytic triad and amidase signature sequence. Kinetics of PpFAAH1 showed specificity towards anandamide (AEA) at 37°C and pH 8.0. Further biophysical and bioinformatic analyses revealed that, structurally, PpFAAH1 to PpFAAH4 were closely associated to the plant FAAH whereas PpFAAH6 to PpFAAH9 were more closely associated to the animal FAAH. A substrate entry gate or ‘dynamic paddle’ in FAAH is fully formed in vertebrates but absent or not fully developed in non-vertebrates and plants. In planta analysis revealed that PpFAAH responded differently with saturated and unsaturated N-acylethanolamines (NAEs). In vivo amidohydrolase activity showed specificity associated with developmental stages. Additionally, overexpression of PpFAAH1 indicated the need for NAEs in developmental transition. To understand and identify key molecules related to endocannabinoid signaling in P. patens, we used high-throughput RNA sequencing. We analyzed temporal expression of mRNA and long non-coding RNA (lncRNA) in response not only to exogenous anandamide but also its precursor arachidonic acid and abscisic acid (ABA, a stress hormone). From the 40 RNA-seq libraries generated, we identified 4244 novel lncRNAs. The highest number of differentially expressed genes (DEGs) for both mRNA and lncRNA were detected on short-term exposure (1 h) to AEA. Furthermore, gene ontology enrichment analysis showed that 17 genes related to activation of the G protein-coupled receptor signaling pathway were highly expressed along with a number of genes associated with organelle relocation and localization. We identified key signaling components of AEA that showed significant difference when compared with ABA. This study provides a fundamental understanding of novel endocannabinoid signaling in early land plants and a future direction to elucidate its functional role.

Les MICI (maladies inflammatoires chroniques de l'intestin) invalident 200 000 personnes en France. La région Nord-Pas-de-Calais est particulièrement touchée par ces affections et les traitements disponibles pour ces pathologies demeurent coûteux et peu nombreux. Des études récentes ont suggéré que le système endocannabinoïde, exprimé au seing du tractus gastro-intestinal, est une cible thérapeutique prometteuse pour le traitement des MICI. Ce système se compose des récepteurs aux cannabinoïdes CB1 et CB2, des ligands endogènes de ces récepteurs, notamment l'anandamide et le 2-arachidonoylglycérol et des protéines impliquées dans l'anabolisme et le catabolisme des ligands. L'anandamide a présenté des capacités à prévenir la colite induite par le TNBS à des rongeurs. Toutefois, in vivo ce composé possède un temps de demi-vie court et est rapidement dégradé par une amidase à sérine, la FAAH (Fatty Acid Amide Hydrolase). Nous avons ainsi envisagé la conception, la synthèse et l'évaluation pharmacologique de nouveau inhibiteurs de la FAAH. L'une de nos molécules, le composé 95, présentant une CI50 sur l'enzyme de 88 nM a ensuite été injectée par voie intrapéritonéale à des souris dont la colite a été induite trois jours plus tard par l'injection intrarectale de TNBS. L'évaluation des scores macroscopiques et microscopiques des dommages causés sur le côlon par l'agent irritant a ensuite été effectuée. L'inflammation du côlon a été significativement réduite chez le groupe de souris ayant été traité par le composé 95, montrant que l'inhibition de la FAAH est une stratégie thérapeutique efficace dans le traitement des MICI.

The Endocannabinoid system has been found in the gastrointestinal tract, where it plays an important role in gut under both physiological and pathological conditions. Although the major effects of cannabinoids in the gut are mediated through effects on enteric neurons, the role of cannabinoids in the enteric nervous system is poorly understood. In the present study, we have used the primary cultures of myenteric ganglia and a newly developed fetal enteric neuronal cell line to identify whether the endocannabinoid, anandamide, affects ganglionic and neuronal survival and the pathways involved. Anandamide had a biphasic effect on ganglionic survival, increasing survival at low concentrations (1nM-0.1uM) and decreasing survival at high concentrations (1-10uM). Maximal survival (68% increase in number of ganglia surviving) occurred at 0.1uM and the ED50 was 3nM. This effect on promoting survival was inhibited by the CB1 antagonist AM251 (1uM) and by AraC (10uM), but not the CB2 antagonist AM630 (1uM). AM630 (1uM) significantly blocked the decreased survival induced by high concentration anandamide (10uM). The enteric glia was involved in anandamide-induced ganglion survival. Anandamide had no effect on the number of neurons/ganglion in the presence of enteric glia, but decreased the number of neurons/ganglion by 15-20% in absence of enteric glia. This effect was partially reversed by CB1 antagonist, AM251 (1uM) (20%-145% at 1nM-10uM) and by CB2 antagonist AM630 (1uM) (40%-185% at 1nM-10uM). In the fetal enteric neural cell line (IM-FEN), anandamide decreased enteric neuronal survival in a concentration-dependent manner at both 39 and 33 degree (11-45% and 10-22%decrease in survival at 1nM-10uM, respectively). Coculture of astrocytes with the enteric neuronal cells was not able to reverse anandamide-mediated neuronal death. Immunocytochemistry and western blot confirmed that the presence of both CB1 and CB2 receptors in enteric neurons (primary cultures and IM-FEN) and glia (primary cultures). In addition, the PLC-beta inhibitor U73122 (1uM) inhibited anandamide induced ganglia survival significantly. Anandamide also induced increased expression of phospho-P44/42MAPK (13-48% at 1nM-10uM) and phospho-AKT (1-28% at 1 nM-10uM) in IM-FEN. We conclude that anandamide has a differential effect on survival of enteric ganglia and neurons. It promotes ganglionic and neuronal survival by CB1 receptors in the presence of glia and this involves the PLC-beta pathway. Conversely, anandamide promotes neuron death in absence of glia as a result of effects on both the MAPK and PI-3K/AKT pathways. Since the endocannabinoid system is upregulated in inflammatory bowel diseases, these effects may play a role in the pathogenesis of the response to inflammation as well as the recovery and reinnervation of the gut following the acute phase of inflammation. The further significance of this work could contribute to developing new therapeutic methods for treatment of inflammatory bowel disease and related symptoms in clinic practice.

In both vertebrates and invertebrates, including leeches, microglia are rapidly activated by central nervous system (CNS) damage and migrate to the lesions. Adenosine triphosphate (ATP), nitric oxide (NO) and endocannabinoids have been implicated in controlling activation and migration, but details of the mechanisms are uncertain. This dissertation tests the hypothesis that endocannabinoids coordinate and influence the microglial response to nerve cord crushing. Chapter 1 reports that application of endocannabinoids to nerve cords at concentrations as low as 100 nM for arachidonylethanolamide (anandamide, or AEA) reduced the number of migrating microglia, but not when cords were pretreated with 10 µM of the CB2 cannabinoid receptor (CB2R) antagonist SR144528. In addition, immunoblots confirmed the expression of CB1-like and CB2-like receptors and immunohistochemistry showed that they were concentrated at lesions, where microglia accumulated. Benzoyl ATP (BzATP) also reduced microglia accumulation, an effect blocked by pretreatment of nerve cords with SR144528, whereas the G-protein coupled P2YR agonists uridine triphosphate (UTP) and methylthio-ATP (MeSATP) at 100 µM did not reduce accumulation. This result suggested that P2X7R activation elicited production and release of a CB2R agonist that influenced microglia movement. Chapter 2 reports that extracellular ATP levels were highest in the CNS within the first 30 min of injury and remained above unharmed controls for at least 2 hours. Application of 10 units (U) of the ATPase apyrase to nerve cords reduced accumulation of microglia at lesions, another indication that microglia require extracellular ATP to accumulate. Chapter 3 reports that AEA stopped ATP-induced movement of microglia, and that this effect was blocked by pretreatment of nerve cords with the CB1R antagonist SR141716A (10µM), the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L NAME, 2 mM) or the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-teramethylimidazoline-oxyl-3-oxide (carboxy-PTIO or cPTIO, 1 mM). Thus the migration of microglia to lesions is regulated not only by ATP acting on P2YR and by NO acting on soluble guanylate cyclase (sGC), but also potentially by ATP binding to P2X7-like receptors to increase the production of cannabinoids. Cannabinoids, binding to the CB1R and CB2R cause production of NO, which suppresses microglia movement.

No description available.

No description available.

No description available.

In plants, saturated and unsaturated N-Acylethanolamines (NAEs) with acyl chains 12C to 18C are reported for their differential levels in various tissues and species. While NAEs were shown to play a vital role in mammalian neurological and physiological functions, its metabolism and functional implications in plants however, remains incomplete. Recently, anandamide (NAE 20:4), an essential fatty acid neurotransmitter in mammalian system, was identified in moss Physcomitrella patens, in addition to other types of NAEs. Bryophytes display high tolerance to abiotic stress and thus presence of anandamide in moss, but not in higher plants, suggests that NAE 20:4 might have contributed to their survival in harsh environmental conditions. Therefore, we hypothesize the anandamide metabolic pathway might play a role in mediating stress responses in P. patens. To this extent, using previously identified NAE-metabolic genes in mouse and/or Arabidopsis as templates, we identified moss orthologs for enzymes that likely participate in anandamide metabolism. We identified members of metallo-hydrolase superfamily and a/Β-hydrolase4, and five putative fatty acid amide hydrolases, which may hydrolyze N-acylphosphatidylethanolamine and NAE, respectively. Electronic fluorescent pictograph analyses of these orthologs in moss revealed differential developmental stage-specific expression patterns in gametophyte and sporophyte stages. We are currently examining expression pattern for these putative NAE-metabolic pathway genes, along with anandamide levels, in different tissues and developmental stages of moss subjected to water stress in the presence of anandamide. These transcript and metabolite levels in moss subjected to stress are expected to offer better understanding of the role of anandamide in mediating stress responses and further allow us to identify candidate genes that might participate in NAE metabolism. Our studies are aimed at functional validation of candidate genes and generating moss transgenic lines with altered NAE metabolite profile. Our long-term goal is to conduct comprehensive analyses of NAE metabolite mutants to determine their role in growth and development, and mediating stress responses in plants.

In higher plants, a class of bioactive fatty acid ethanolamides or N-acylethanolamines (NAEs) mediate growth, development, cellular organization and response to stress, in an abscisic acid (ABA)-dependent or independent manner. Unlike in higher plants, Physcomitrella patens, a bryophyte contains anandamide or NAE 20:4, a mammalian endocannabinoid ligand that mediates a multitude of physiological functions including development and stress. Unique lipids in mosses are considered vital for their resilience to environmental stresses; such lipids might enable them to recognize stress at the cellular level, and respond with membrane reorganization and altered growth. Since the identification of anandamide in moss, we have shown that, like abscisic acid (ABA), it inhibits gametophyte growth in a dose-dependent manner and reduced chlorophyll content. It is hypothesized that moss gametophores undergo morphological and cellular changes during anandamide-mediated growth inhibition. To test this, gametophyte growth and morphological changes in phyllodes, under different concentrations of NAE 20:4, were digitally captured using Canon EOS 70D, and analyzed using ImageJ software. NAE 20:4 but not its free fatty acid, arachidonic acid, not only inhibited growth of both shoots and rhizoids in a dose-dependent manner but also showed remarkable cellular changes. Phyllodes and protonemal cells of NAE 20:4 treated plants were further examined under stereo and compound light microscopes. Long- and short-term treatment with anandamide resulted in reduced chloroplast number, cytoplasmic shrinkage and plasmolysis in phyllodes and protonemal cells. A 100 micromolar NAE 20:4 treatment resulted in complete loss of green pigmentation in phyllodes. Effects of anandamide on cytoskeletal organization will be studied using Physcomitrella plants expressing GFP-talin and tubulin, via confocal microscopy. Together, these data will provide insights into anandamide-mediated cellular responses during growth inhibition.